Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 21862443)

1.

Ursodeoxycholic acid in cystic fibrosis-associated liver disease.

Ooi CY, Nightingale S, Durie PR, Freedman SD.

J Cyst Fibros. 2012 Jan;11(1):72-3; author reply 74-75. doi: 10.1016/j.jcf.2011.08.002. Epub 2011 Aug 23. No abstract available.

2.

Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease.

Debray D, Kelly D, Houwen R, Strandvik B, Colombo C.

J Cyst Fibros. 2011 Jun;10 Suppl 2:S29-36. doi: 10.1016/S1569-1993(11)60006-4. Review.

3.

Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.

O'Brien SM, Campbell GR, Burke AF, Maguire OC, Rowlands BJ, FitzGerald MX, Hegarty JE.

Eur J Gastroenterol Hepatol. 1996 May;8(5):477-83.

PMID:
8804877
4.

Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease.

Siano M, De Gregorio F, Boggia B, Sepe A, Ferri P, Buonpensiero P, Di Pasqua A, Raia V.

Dig Liver Dis. 2010 Jun;42(6):428-31. doi: 10.1016/j.dld.2009.07.022. Epub 2010 Jan 19.

PMID:
20034860
5.
6.
7.

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, Zimmer-Nechemias L, Setchell KD.

Hepatology. 1992 Oct;16(4):924-30.

PMID:
1398498
9.

Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease.

Nousia-Arvanitakis S, Fotoulaki M, Economou H, Xefteri M, Galli-Tsinopoulou A.

J Clin Gastroenterol. 2001 Apr;32(4):324-8.

PMID:
11276276
10.

Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review.

Cheng K, Ashby D, Smyth R.

J R Soc Med. 1997;90 Suppl 31:6-12. Review. No abstract available.

11.

Oral bile acids in cystic fibrosis-associated liver disease.

Colombo C, Crosignani A, Apostolo MG, Marzano MT, Bettinardi N, Giunta A.

J R Soc Med. 1994;87 Suppl 21:20-4. Review. No abstract available.

13.

Liver disease in cystic fibrosis.

Tanner MS, Taylor CJ.

Arch Dis Child. 1995 Apr;72(4):281-4. Review. No abstract available.

14.

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.

Colombo C, Setchell KD, Podda M, Crosignani A, Roda A, Curcio L, Ronchi M, Giunta A.

J Pediatr. 1990 Sep;117(3):482-9.

PMID:
2391610
15.

Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.

Smith JL, Lewindon PJ, Hoskins AC, Pereira TN, Setchell KD, O'Connell NC, Shepherd RW, Ramm GA.

Hepatology. 2004 Jun;39(6):1673-82.

PMID:
15185309
16.

[Hepatobiliary disease in cystic fibrosis].

PĂ©rez-Aguilar F, Berenguer Lapuerta J.

Med Clin (Barc). 1998 Sep 19;111(8):302-6. Review. Spanish. No abstract available.

PMID:
9810550
17.

Ursodeoxycholic acid in the treatment of chronic liver disease.

Cirillo NW, Zwas FR.

Am J Gastroenterol. 1994 Sep;89(9):1447-52. Review.

PMID:
8079918
18.

Analysis of risk factors for the development of liver disease associated with cystic fibrosis.

Colombo C, Apostolo MG, Ferrari M, Seia M, Genoni S, Giunta A, Sereni LP.

J Pediatr. 1994 Mar;124(3):393-9.

PMID:
8120708
19.

Cystic fibrosis-associated liver disease.

Herrmann U, Dockter G, Lammert F.

Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):585-92. doi: 10.1016/j.bpg.2010.08.003. Review.

PMID:
20955961
20.

Liver disease in cystic fibrosis.

Colombo C.

Curr Opin Pulm Med. 2007 Nov;13(6):529-36. Review.

PMID:
17901760
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk